MARATTO

article · Open Forum Infectious Diseases

Adjunct Diagnostic Accuracy of Antigen-specific Interleukin-2 for Latent Tuberculosis Infection in Pregnancy

2026Open accessMakerere University

Abstract

Background: containment, mainly by inducing the proliferation of T cells. However, the role of IL-2 in latent tuberculosis (TB) infection (LTBI) screening has not been completely explored. We, therefore, evaluated the diagnostic accuracy and optimal cutoff value (OCV) of IL-2 as a potential adjunct biomarker for screening LTBI during pregnancy. Methods: -specific IL-2 culture supernatants using STATA 18.0. The OCV was determined using the Youden index, considering sensitivity and specificity. Results: < .001). IL-2 achieved an AUC of 0.88 (95% CI: 0.82-0.93), with 76% sensitivity and 96% specificity. IFN-γ showed an AUC of 0.83 (95% CI: 0.76-0.90), with 78% sensitivity and 90% specificity. The combined IL-2 + IFN-γ response yielded the highest accuracy, with an AUC of 0.89 (95% CI: 0.83-0.94), 77% sensitivity, and 95% specificity. Conclusions: -specific IL-2 culture supernatant levels showed good discriminatory power for LTBI detection in pregnancy, comparable to IFN-γ, with the combined IL-2+ IFN-γ response yielding the highest accuracy. These findings support the potential utility of IL-2, alone or with IFN-γ, as an adjunct biomarker for LTBI screening in pregnant women, warranting further validation in larger, diverse cohorts.

Research topics

  • Tuberculosis Research and Epidemiology
  • Diagnosis and treatment of tuberculosis
  • Infectious Diseases and Tuberculosis

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1093/ofid/ofag237

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.